Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
Screening for SMA in Newborns Alleviates Functional Burden, Associated Comorbidities
January 17th 2023A study found that screening for spinal muscular atrophy (SMA) in newborns paired with early access to disease-modifying therapies was effective in alleviating the burden and comorbidities of the disease.
4-Dose COVID-19 Vaccine Less Effective Beyond 90 Days
January 16th 2023A new study has found that vaccine effectiveness against infection after 4 doses of the COVID-19 vaccine disappeared after 90 days for Omicron variants BA.2, BA.2.12.1, BA.4, and BA.5, although it remained effective against hospitalizations.
Vaccinated, Unvaccinated First Responders Have Significantly Different Beliefs About Effectiveness
January 13th 2023Depending on their COVID-19 vaccination status, there were differences in the sources first responders in Kentucky preferred to receive information from, their willingness to believe conspiracy theories, and the perceived risk of the virus.
Symptoms That Contribute to SMA Disease Burden Clarified in New Study
January 12th 2023Qualitative interviews conducted with caregivers of children with spinal muscular atrophy (SMA) found that the symptoms with the greatest effect on disease burden were not always the most prevalent symptoms in patients.
Contraction, Mortality Rate of COVID-19 Was Lower in Vaccinated Patients With PAH
January 9th 2023Patients with pulmonary arterial hypertension (PAH) were more likely to die or be hospitalized if they contracted COVID-19 but were less likely to die from COVID-19 if they were vaccinated against SARS-CoV-2.
Patients With SMA, Family Members Need Empathetic Attitude From Diagnosing Physician
January 6th 2023Patients who receive a diagnosis of spinal muscular atrophy (SMA) require an empathetic approach from their primary care physician when receiving the diagnosis and evaluating options, according to recent study findings.
Tumor-Associated Autoantibodies Demonstrate Promise as Immunotherapy Biomarkers in NSCLC
January 5th 2023The development of 2 panels measuring levels of tumor-associated autoantibodies (TAAbs) has promise for predicting therapeutic response and adverse events for patients with advanced non–small cell lung cancer (NSCLC) after immune checkpoint inhibitor–based treatment.
Administering Antimicrobial Therapy Before CIT May Be Safer Option in NSCLC
January 5th 2023This study investigated the effects of antimicrobial therapy among patients with non–small cell lung cancer (NSCLC) who received immunotherapy with a checkpoint inhibitor or chemotherapy plus immunotherapy (CIT).
2 Commerce Drive
Cranbury, NJ 08512